About Us Contact Us Sitemap

NGS-Based RNA-Sequencing Market, By Type (Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA), Targeted RNA Sequencing, Single-Cell RNA Sequencing (scRNA-Seq), mRNA Sequencing, Total RNA Sequencing, and De Novo Transcriptome Assembly ), By Application, By Component, By Technology, By End User, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Market Research Image
Report ID AV1513
Published Date May 2026
Pages 413
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

NGS-Based RNA-Sequencing Market size was valued at US$ 4,587.82 Million in 2025, expanding at a CAGR of 17.09% from 2026 to 2033.

NGS-based RNA sequencing, commonly known as RNA-Seq, is an advanced molecular analysis technique that uses next-generation sequencing technology to study RNA within cells. It enables researchers to examine gene activity, expression levels, and cellular responses across a wide range of biological conditions. By sequencing millions of RNA fragments simultaneously, RNA-Seq provides a faster, more comprehensive, and highly detailed view of the transcriptome compared to traditional gene expression analysis methods. In this process, RNA molecules are first converted into sequencing libraries, which are then analyzed to identify gene expression patterns and functional biological changes.

RNA-Seq has become an essential tool in disease research, drug discovery, and precision medicine because of its ability to reveal how genes function within real biological systems. The growth and adoption of RNA sequencing technologies are supported by global public health priorities and government-backed scientific initiatives. For example, the World Health Organization emphasizes the importance of genomic surveillance for monitoring infectious diseases, while the National Institutes of Health supports large-scale transcriptomics and sequencing research to improve disease understanding and therapeutic development. In Europe, the European Commission promotes collaborative genomics initiatives aimed at advancing personalized healthcare across member states. Similarly, the Department of Biotechnology continues to strengthen sequencing research infrastructure and support genomics-based scientific studies.

NGS-Based RNA-Sequencing Market- Market Dynamics

Growing Adoption of RNA Sequencing in Precision Medicine and Disease Research

Rising clinical acceptance of precision medicine and deeper disease understanding is becoming a key driver for the NGS-based RNA sequencing market, as healthcare systems progressively shift from generalized treatment approaches toward more patient-specific decision-making. RNA sequencing enables clinicians and researchers to analyze gene expression patterns at an individual level, supporting the identification of disease mechanisms with greater biological precision.

In the United Kingdom, the Department of Health and Social Care has integrated genomic technologies into the NHS Genomic Medicine Service to improve the diagnosis of rare diseases and cancer through sequencing-based approaches. Similarly, India’s Department of Biotechnology is advancing clinical genomics and translational research initiatives that utilize sequencing data to enhance disease understanding and healthcare outcomes. From an industry perspective, Illumina provides sequencing platforms widely used in clinical laboratories for gene expression analysis and precision medicine applications. Likewise, Thermo Fisher Scientific offers RNA sequencing solutions that support hospitals and research institutions in studying disease mechanisms and improving treatment strategies.

NGS-Based RNA-Sequencing Market- Segmentation Analysis:
The Global NGS-Based RNA-Sequencing Market is segmented on the basis of Type, Application, Component, Technology, End User, and Region.

Based on type classification, the market is segmented into six categories. Among these, mRNA sequencing holds a significant position as it is widely used for studying gene expression patterns across both research and clinical applications. It offers high accuracy, scalability, and standardized workflows for transcriptome analysis. Its adoption is further supported by a well-established workflow and compatibility with most sequencing platforms, making it a preferred method for gene expression profiling. For instance, QIAGEN provides RNA library preparation kits that are widely used in transcriptome workflows, supporting standardized mRNA sequencing in research laboratories. Similarly, Oxford Nanopore Technologies offers direct RNA sequencing kits that enable full-length mRNA analysis and real-time transcript detection in biological studies.

Cancer genomics also represents a significant application area in this market, as it supports the understanding of tumor biology through gene expression profiling and detection of transcript variations. This helps researchers better study disease progression and evaluate therapy responses in a more precise manner. Companies such as Pacific Biosciences provide long-read sequencing technologies that enable full-length RNA transcript analysis, improving the identification of complex cancer-related isoforms. Likewise, BGI Genomics supports large-scale cancer transcriptome studies that help in understanding tumor heterogeneity and advancing research in targeted therapy development.

NGS-Based RNA-Sequencing Market- Geographical Insights

From a regional perspective, the NGS-based RNA sequencing market is shaped by national genomics policies, biomedical research funding, and a growing emphasis on precision healthcare. The Asia-Pacific region is expected to register significant growth, supported by expanding scientific infrastructure and strengthening molecular research capabilities across multiple countries. This growth is driven by strong government-backed genomic programs and increasing adoption of transcriptomic technologies in both disease research and clinical applications.

Across the region, governments are actively supporting this expansion through structured initiatives. In China, the National Natural Science Foundation of China and the National Health Commission of the People's Republic of China support multi-omics and RNA sequencing research to advance understanding of disease mechanisms and promote biomedical innovation. In Japan, the Ministry of Education, Culture, Sports, Science and Technology along with the Japan Agency for Medical Research and Development continues to fund life sciences and genomic medicine programs that integrate RNA sequencing into advanced research frameworks.

In India, the Department of Biotechnology and the Indian Council of Medical Research are supporting genomic surveillance and transcriptomic research for infectious and rare disease studies, strengthening national research capacity. In addition, companies such as MedGenome provide RNA sequencing and multi-omics services to research institutions and pharmaceutical organizations, enhancing applied genomics capabilities and data interpretation. Overall, the combination of government-led programs, institutional funding, and private sector participation is accelerating the development of RNA sequencing applications in the region and promoting broader integration of transcriptomics into healthcare and life sciences.

UK NGS-Based RNA-Sequencing Market- Country Insights

The United Kingdom represents a steadily evolving landscape in the NGS-based RNA sequencing market, supported by strong national research programs and a well-established genomic infrastructure. The government has prioritized the integration of sequencing technologies into public health and biomedical research frameworks. The Department of Health and Social Care has advanced national genomics initiatives through the NHS Genomic Medicine Service, which incorporates RNA sequencing to improve rare disease diagnosis and support cancer research applications.

At the same time, UK Research and Innovation, through the Medical Research Council, continues to fund transcriptomics and multi-omics research projects aimed at advancing understanding of disease mechanisms at the molecular level. From an industry perspective, Oxford Nanopore Technologies plays a key role by offering real-time sequencing platforms widely used in RNA sequencing workflows for both research and clinical applications. Overall, the combination of structured government initiatives, integration within public healthcare systems, and strong domestic technological capabilities supports the continued expansion and adoption of RNA sequencing across research and healthcare sectors in the United Kingdom.

NGS-Based RNA-Sequencing Market- Competitive Landscape:

Amid the growing demand for accurate viral detection and safer diagnostic workflows, the virology specimen collection market is shaped by a mix of diagnostic manufacturers and laboratory solution providers. Companies such as Becton, Dickinson and Company, QIAGEN, Copan Italia, Roche, and Puritan Medical Products supply swabs, transport media, and integrated specimen collection systems that support hospitals, research institutions, and public health programs. These players focus on improving sample stability, biosafety standards, and ease of use while ensuring compatibility with advanced molecular testing platforms.

Distribution is enabled through hospital procurement systems, laboratory supply networks, and direct institutional partnerships, ensuring wide accessibility across healthcare settings. Recent developments in adjacent genomic technologies also continue to influence the broader diagnostics landscape. For example, Oxford Nanopore Technologies expanded its RNA sequencing workflow support with enhanced real-time analysis tools in 2025, improving flexibility in transcriptomic research. Similarly, 10x Genomics strengthened its single-cell RNA sequencing platform by introducing upgraded sample processing and cloud-based analytical capabilities, reflecting a shift toward more integrated and scalable genomic research solutions.

Recent Developments

  • In January 2026, Illumina announced an expansion of its high-throughput sequencing portfolio with improved RNA-Seq workflows designed to enhance speed and data accuracy for large-scale transcriptomics studies, supporting increasing demand in clinical and research applications.

  • In November 2025, Thermo Fisher Scientific entered a collaboration with Pfizer to advance RNA-based research workflows, including sequencing applications for drug development and biomarker discovery, supporting more integrated and efficient approaches to RNA-driven biomedical research.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NGS-BASED RNA-SEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • QIAGEN
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • Roche
  • 10x Genomics
  • Bio-Rad Laboratories
  • PerkinElmer
  • Eurofins Scientific
  • Macrogen
  • Takara Bio
  • Novogene
  • Danaher
  • Becton Dickinson
  • GenScript
  • Azenta Life Sciences
  • Sequenome Genomics
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA)
  • Targeted RNA Sequencing
  • Single-Cell RNA Sequencing (scRNA-Seq)
  • mRNA Sequencing
  • Total RNA Sequencing
  • De Novo Transcriptome Assembly 
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Cancer Genomics
  • Precision Medicine
  • Biomarker Discovery 
  • Plant And Microbial Transcriptomics 
  • Single-Cell Transcriptomics in Immuno-Oncology
  • Drug Discovery & Development
  • Disease Mechanism Studies
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Sequencing
  • Storage & Cloud Bioinformatics
  • Library Preparation & Sample Processing
  • Data Analysis & Interpretation
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Nanopore Sequencing (Oxford Nanopore)
  • Sequencing By Synthesis (SBS)
  • Third-Generation Sequencing (PacBio, ONT)
  • SOLiD & Pyrosequencing (Legacy/Declining)
  • Ion Semiconductor Sequencing 
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Government and Non-Profit Organizations
  • Contract Research Organizations (CROs) 
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Clinical & Diagnostic Laboratories
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. NGS-Based RNA-Sequencing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. NGS-Based RNA-Sequencing Market Snippet by Type
2.1.2. NGS-Based RNA-Sequencing Market Snippet by Application
2.1.3. NGS-Based RNA-Sequencing Market Snippet by Component
2.1.4. NGS-Based RNA-Sequencing Market Snippet by Technology
2.1.5. NGS-Based RNA-Sequencing Market Snippet by End User
2.1.6. NGS-Based RNA-Sequencing Market Snippet by Country
2.1.7. NGS-Based RNA-Sequencing Market Snippet by Region
2.2. Competitive Insights
3. NGS-Based RNA-Sequencing Key Market Trends
3.1. NGS-Based RNA-Sequencing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. NGS-Based RNA-Sequencing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. NGS-Based RNA-Sequencing Market Opportunities
3.4. NGS-Based RNA-Sequencing Market Future Trends
4. NGS-Based RNA-Sequencing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. NGS-Based RNA-Sequencing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. NGS-Based RNA-Sequencing Market Landscape
6.1. NGS-Based RNA-Sequencing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. NGS-Based RNA-Sequencing Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA)
7.1.3. Targeted RNA Sequencing
7.1.4. Single-Cell RNA Sequencing (scRNA-Seq)
7.1.5. mRNA Sequencing
7.1.6. Total RNA Sequencing
7.1.7. De Novo Transcriptome Assembly
7.1.8. Others
8. NGS-Based RNA-Sequencing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Cancer Genomics
8.1.3. Precision Medicine
8.1.4. Biomarker Discovery 
8.1.5. Plant And Microbial Transcriptomics 
8.1.6. Single-Cell Transcriptomics in Immuno-Oncology
8.1.7. Drug Discovery & Development
8.1.8. Disease Mechanism Studies
8.1.9. Others
9. NGS-Based RNA-Sequencing Market – By Component
9.1. Overview
9.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
9.1.2. Sequencing
9.1.3. Storage & Cloud Bioinformatics
9.1.4. Library Preparation & Sample Processing
9.1.5. Data Analysis & Interpretation
9.1.6. Others
10. NGS-Based RNA-Sequencing Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Nanopore Sequencing (Oxford Nanopore)
10.1.3. Sequencing By Synthesis (SBS)
10.1.4. Third-Generation Sequencing (PacBio, ONT)
10.1.5. SOLiD & Pyrosequencing (Legacy/Declining)
10.1.6. Ion Semiconductor Sequencing 
10.1.7. Others
11. NGS-Based RNA-Sequencing Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Government and Non-Profit Organizations
11.1.3. Contract Research Organizations (CROs) 
11.1.4. Pharmaceutical & Biotechnology Companies
11.1.5. Academic & Research Institutions
11.1.6. Clinical & Diagnostic Laboratories
11.1.7. Others
12. NGS-Based RNA-Sequencing Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. NGS-Based RNA-Sequencing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. NGS-Based RNA-Sequencing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. NGS-Based RNA-Sequencing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. NGS-Based RNA-Sequencing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. NGS-Based RNA-Sequencing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- NGS-Based RNA-Sequencing Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Illumina
13.2.2. Thermo Fisher Scientific
13.2.3. Agilent Technologies
13.2.4. QIAGEN
13.2.5. Pacific Biosciences
13.2.6. Oxford Nanopore Technologies
13.2.7. BGI Genomics
13.2.8. Roche
13.2.9. 10x Genomics
13.2.10. Bio-Rad Laboratories
13.2.11. PerkinElmer
13.2.12. Eurofins Scientific
13.2.13. Macrogen
13.2.14. Takara Bio
13.2.15. Novogene
13.2.16. Danaher
13.2.17. Becton Dickinson
13.2.18. GenScript
13.2.19. Azenta Life Sciences
13.2.20. Sequenome Genomics
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NGS-BASED RNA-SEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • QIAGEN
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • Roche
  • 10x Genomics
  • Bio-Rad Laboratories
  • PerkinElmer
  • Eurofins Scientific
  • Macrogen
  • Takara Bio
  • Novogene
  • Danaher
  • Becton Dickinson
  • GenScript
  • Azenta Life Sciences
  • Sequenome Genomics
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA)
  • Targeted RNA Sequencing
  • Single-Cell RNA Sequencing (scRNA-Seq)
  • mRNA Sequencing
  • Total RNA Sequencing
  • De Novo Transcriptome Assembly 
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Cancer Genomics
  • Precision Medicine
  • Biomarker Discovery 
  • Plant And Microbial Transcriptomics 
  • Single-Cell Transcriptomics in Immuno-Oncology
  • Drug Discovery & Development
  • Disease Mechanism Studies
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Sequencing
  • Storage & Cloud Bioinformatics
  • Library Preparation & Sample Processing
  • Data Analysis & Interpretation
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Nanopore Sequencing (Oxford Nanopore)
  • Sequencing By Synthesis (SBS)
  • Third-Generation Sequencing (PacBio, ONT)
  • SOLiD & Pyrosequencing (Legacy/Declining)
  • Ion Semiconductor Sequencing 
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Government and Non-Profit Organizations
  • Contract Research Organizations (CROs) 
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Clinical & Diagnostic Laboratories
  • Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Request For Sample
Choose License Type
assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

Email:

[email protected]

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

QUICK LINKS
RESOURCES
Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved